Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
8,834 | Dovepress* | 7,104 | 645+ | 1,928 | 7,749 |
PubMed Central* | 0 | 1,085 | 352 | 1,085 | |
Totals | 7,104 | 1,730 | 2,280 | 8,834 | |
*Since 6 December 2012 +Since July 2016 |
View citations on PubMed Central and Google Scholar